CAH240705P131000
- 32.90
- 0.000.00%
Cardinal Health Newsroom
Wells Fargo Maintains Cardinal Health(CAH.US) With Sell Rating, Raises Target Price to $95
Wells Fargo analyst Steve Baxter maintains $Cardinal Health(CAH.US)$ with a sell rating, and adjusts the target price from $94 to $95.According to TipRanks data, the analyst has a success rate of 51.6
Analysts Conflicted on These Healthcare Names: Cardinal Health (CAH) and Apellis Pharmaceuticals (APLS)
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
Evercore Maintains Cardinal Health(CAH.US) With Hold Rating, Cuts Target Price to $105
Evercore analyst Elizabeth Anderson CFA maintains $Cardinal Health(CAH.US)$ with a hold rating, and adjusts the target price from $110 to $105.According to TipRanks data, the analyst has a success
Evercore ISI Adjusts Cardinal Health's Price Target to $105 From $115, Keeps In Line Rating
Cardinal Health (CAH) has an average rating of hold and price targets ranging from $92 to $130, according to analysts polled by Capital IQ.Price: 97.73, Change: +0.85, Percent Change: +0.88
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $130
Baird analyst Eric Coldwell maintains $Cardinal Health(CAH.US)$ with a buy rating, and adjusts the target price from $128 to $130.According to TipRanks data, the analyst has a success rate of 52.5%
Cardinal Health Price Target Raised to $130.00/Share From $129.00 by Baird
Cardinal Health Price Target Raised to $130.00/Share From $129.00 by
Cardinal Health Is Maintained at Outperform by Baird
Cardinal Health Is Maintained at Outperform by
Baird Maintains Outperform on Cardinal Health, Raises Price Target to $130
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $129 to $130.
Cardinal Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/09/2024 34.76% Baird $129 → $130 Maintains Outperform 05/15/2024 19.21% Argus Research $120 → $115
Express News | Cardinal Health Inc : Baird Raises Target Price to $130 From $129
Leerink Adjusts Price Target on Cardinal Health to $122 From $120, Maintains Outperform Rating
Cardinal Health (CAH) has an average hold rating and a price target range of $92 to $129, according to analysts polled by Capital IQ.Price: 95.91, Change: +0.02, Percent Change: +0.02
Express News | Cardinal Health Inc : Leerink Partners Raises Target Price to $122 From $120
From Lab Rats And Eyeballs To Cannabis: Scarlet Express CEO Discusses Closed-Loop Delivery, How To 'Survive In Chaos'
First, Claudia Post oversaw the safe delivery of eyeballs, kidneys and other organs. Today? Her specialty is cannabis. Most recently, she launched Scarlet Express with financial backing from Ben Sopr
Top High Quality Stocks That Pay Dividends - UBS
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 2.37% on an annualized basis producing an average annual return of 15.18%. Currently, Cardinal Health has a market capit
Cardinal Health To Go Ex-Dividend On July 1st, 2024 With 0.5056 USD Dividend Per Share
June 27th (Eastern Time) - $Cardinal Health(CAH.US)$ is trading ex-dividend on July 1st, 2024.Shareholders of record on July 1st, 2024 will receive 0.5056 USD dividend per share on July 15th, 2024. Th
Cardinal Health (CAH) Stock Sinks As Market Gains: What You Should Know
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 4.45% on an annualized basis producing an average annual return of 17.8%. Currently, Cardinal Health has a market capita
Mizuho Securities Maintains Cardinal Health(CAH.US) With Hold Rating, Maintains Target Price $104
Mizuho Securities analyst Ann Hynes maintains $Cardinal Health(CAH.US)$ with a hold rating, and maintains the target price at $104.According to TipRanks data, the analyst has a success rate of 57.9% a